Skip to content

Adductor canal block combined with local infiltration analgesia for postoperative pain and knee function after anterior cruciate ligament reconstruction

Adductor canal block combined with local infiltration analgesia for postoperative pain and knee function after anterior cruciate ligament reconstruction

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022346
Enrollment
Unknown
Registered
2019-04-07
Start date
2019-04-06
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACL reconstruction

Interventions

Sponsors

Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The patients undergoing ACL reconstruction; (2) Normal platelet and coagulation function preoperatively; (3) Normal intravenous ultrasound in the lower extremities preoperatively; (4) To be able to and willing to provide signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Systemic infections such as pulmonary infection or urinary tract infection are not controlled preoperatively; (2) Abnormal immune function or combined immune-related disease preoperatively; (3) Abnormal inflammatory index preoperatively (C-reactive protein > 20 mg/L); (4) Abnormal fibrinolysis index preoperatively (FDP > 5mg/L); (5) Discontinuation of oral anticoagulants or aspirin less than 1 week.

Design outcomes

Primary

MeasureTime frame
VAS pain score;

Secondary

MeasureTime frame
Morphine consumption;Quadriceps muscle strength;Walking distance;DVT, PE;Range of motion;Swelling;PONV;IKDC;Lysholm;Sleep quality;Satisfaction scores;Time for First Analgesic Request;Opioid-Related Adverse Effects;

Countries

China

Contacts

Public ContactJian Li

West China Hospital, Sichuan University

18980601388@163.com+86 18980601388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026